13F

Stock

Spruce Biosciences, Inc.

SPRB · held by 32 managers

Reported value

$48.3M

Holders

32

+7 new · −9 exited

Holders’ est. mark

−$12.4M

Price effect on 22 books still in the name

Largest holder

$7.93M

Ikarian Capital, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Ikarian Capital, LLC121.4K$7.93M−$2.64MCut−$2.64M
MILLENNIUM MANAGEMENT LLC111.9K$7.31MNew
Citadel70K$4.57M−$1.52MCut−$1.52M
ADAR1 Capital Management, LLC58.6K$3.83M−$1.26MCut−$1.22M
Alyeska Investment Group, L.P.51.7K$3.38M−$1.12MCut−$1.12M
WELLINGTON MANAGEMENT GROUP LLP48.8K$3.19M−$1.06MCut−$1.95M
BOOTHBAY FUND MANAGEMENT, LLC42.1K$2.75M−$915.7KCut−$1.43M
Balyasny Asset Management L.P.40K$2.61M−$870.4KCut−$870.4K
Carlyle Group Inc.38.6K$2.52M−$775.1KCut−$775.1K
Quinn Opportunity Partners LLC26.8K$1.75M−$496.3KCut−$234.9K
ExodusPoint Capital Management, LP22K$1.44M−$478.7KCut−$763.7K
VANGUARD CAPITAL MANAGEMENT LLC18.3K$1.2MHeld
BlackRock, Inc.16.9K$1.11M−$368.6KCut−$368.6K
GEODE CAPITAL MANAGEMENT, LLC12.9K$842.7K−$276.6KCut−$266.4K
Squadron Capital Management LLC12.2K$797.3K−$265.5KCut−$5.3M
DIADEMA PARTNERS LP10K$653.5KNew
STEMPOINT CAPITAL LP6.36K$415.6KNew
VANGUARD FIDUCIARY TRUST CO5.51K$360.3KHeld
GOLDMAN SACHS GROUP INC5.51K$359.8KNew
State Street5.4K$352.9K−$117.5KCut−$204.6K
Resolute Capital Asset Partners LLC4K$261.4K−$87KCut−$87K
UBS Group AG3.92K$256.1K−$85.3KCut−$170.9K
Persistent Asset Partners Ltd2.53K$165.2KNew
MORGAN STANLEY1.42K$92.5K−$8.44KAdded$58.7K
Lion Point Capital, LP1K$65.3K−$21.8KCut−$21.8K
CITIGROUP INC939$61.4KNew
Vanguard Global Advisers, LLC452$29.5KHeld
Sound Income Strategies, LLC200$13.9K−$800Cut−$800
JONES FINANCIAL COMPANIES LLLP193$12.2K−$2.02KAdded$4.85K
Tower Research Capital LLC (TRC)140$9.15K−$22Added$9.06K
CALDWELL SUTTER CAPITAL, INC.13$850−$282Cut−$282
Cassaday & Co Wealth Management LLC2$130New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.